BRAINLIFE.ORG





Neuro-Oncology Reviews




Volume 26 Number 4
29 February 2024




Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 4, 29 February






Lv Q, Liu Y, Sun Y, Wu M.
Insight into deep learning for glioma IDH medical image analysis: A systematic review.
Medicine (Baltimore). 2024 Feb 16;103(7):e37150. doi: 10.1097/MD.0000000000037150. PMID: 38363910. Review. ˍ




Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Ependymoma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Sum. 2024 Feb 16. NCBI Bookshelf ID: NBK65742. PMID 26389185. Review. ˍ




Ritchey AK, et al., PDQ Pediatric Treatment Editorial Board.
Childhood Astrocytomas Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2024 Feb 16. NCBI Bookshelf ID: NBK65954. PMID: 26389391. Review. ˍ




Ritchey AK, et al., PDQ Pediatric Treatment Editorial Board.
Diffuse Intrinsic Pontine Glioma (DIPG): Patient Version.
PDQ Cancer Inf Sum. 2024 Feb 16. NCBI Bookshelf ID: NBK600525. PMID: 38377270. Review. ˍ




Yang S, Sun Y, Liu W, Zhang Y, Sun G, Xiang B, Yang J.
Exosomes in Glioma: Unraveling Their Roles in Progression, Diagnosis, and Therapy.
Cancers (Basel). 2024 Feb 18;16(4):823. doi: 10.3390/cancers16040823. PMID: 38398214. Review. ˍ




Singh H, Kumar R, Mazumder A.
Protein kinase inhibitors in the management of cancer: therapeutic opportunities from natural compounds.
J Asian Nat Prod Res. 2024 Feb 19:1-18. doi: 10.1080/10286020.2024.2313546. PMID: 38373215. Review˰ ˍ




Goutnik M, Iakovidis A, Still MEH, Moor RSF, Melnick K, Yan S, Abbas M, Huang J, Ghiaseddin AP.
Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directions.
Neurooncol Adv. 2024 Feb 20;6(1):vdae025. doi: 10.1093/noajnl/vdae025. PMID: 38486856. Review. ˍ




Goyal A, Rao S, Bhat DI, Santosh V.
Glioblastoma with Probable Intratumoral Adenocarcinoma Metastasis: A Rare Report with Review of Literature.
Int J Surg Pathol. 2024 Feb 20:10668969241231979. doi: 10.1177/10668969241231979. PMID: 38378180. Case report; Review˰ ˍ




Haque W, Butler EB, Teh BS.
Personalized radiation therapy for glioblastoma.
Chin Clin Oncol. 2024 Feb 20;13(1):11. doi: 10.21037/cco-23-107. PMID: 38453659. Review. ˍ




Nelson N, Relógio A.
Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock.
NPJ Precis Oncol. 2024 Feb 20;8(1):40. doi: 10.1038/s41698-024-00530-z. PMID: 38378853. Review. ˍ




Romanishin A, Vasilev A, Khasanshin E, Evtekhov A, Pusynin E, Rubina K, Kakotkin V, Agapov M, Semina E.
Oncolytic viral therapy for gliomas: Advances in the mechanisms and approaches to delivery.
Virology. 2024 Feb 20;593:110033. doi: 10.1016/j.virol.2024.110033. PMID: 38442508. Review˰ ˍ




Valle-Garcia D, Pérez de la Cruz V, Flores I, Salazar A, Pineda B, Meza-Sosa KF.
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma.
Int J Mol Sci. 2024 Feb 20;25(5):2464. doi: 10.3390/ijms25052464. PMID: 38473710. Review. ˍ




Guo X, Wang Y, Ma W.
Editorial: Impacts of 2021 WHO classification on the precise diagnosis and management of gliomas.
Front Neurosci. 2024 Feb 21;18:1366523. doi: 10.3389/fnins.2024.1366523. PMID: 38449732. Editorial. ˍ




*Obrador E, Moreno-Murciano P, Oriol-Caballo M, López-Blanch R, Pineda B, Gutiérrez-Arroyo JL, Loras A, Gonzalez-Bonet LG, Martinez-Cadenas C, Estrela JM, Marqués-Torrejón MÁ.
Glioblastoma Therapy: Past, Present and Future.
Int J Mol Sci. 2024 Feb 21;25(5):2529. doi: 10.3390/ijms25052529. PMID: 38473776. Review. ˍ




De Fazio E, Pittarello M, Gans A, Ghosh B, Slika H, Alimonti P, Tyler B.
Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion.
Int J Mol Sci. 2024 Feb 22;25(5):2563. doi: 10.3390/ijms25052563. PMID: 38473812. Review. ˍ




Ius T, Montemurro N, Lombardi G, Berardinelli J, Romano A, Barresi V, Cerretti G, Guarnera A, Tel A, Cavallo LM, Pasqualetti F, Feletti A.
Decoding the puzzle: A multidisciplinary systematic review of adult brainstem glioma.
Crit Rev Oncol Hematol. 2024 Feb 22:104261. doi: 10.1016/j.critrevonc.2024.104261. PMID: 38395241. Guidelines˰ ˍ




Liu J, Lin F, Sun Y, Liu X.
Clinicopathological analysis of rosette-forming glioneuronal tumors.
Diagn Pathol. 2024 Feb 22;19(1):39. doi: 10.1186/s13000-024-01465-6. PMID: 38388383. Observational study; Review. ˍ




de Los Reyes-Nabhan NK, Scheil-Bertram S, Boppudi S, Carl B, Jussen D.
Diffuse Leptomeningeal Glioneuronal Tumor in Adults: Case Report and Literature Review.
Case Rep Oncol. 2024 Feb 23;17(1):337-343. doi: 10.1159/000536400. PMID: 38404404. Case report; Review. ˍ




Margol AS, Molinaro AM, Onar-Thomas A, Resnick A, Hanson D, Kieran M, Mishra-Kalyani P, Rivera D, Barone A, Arons D, Meehan C, Prados M.
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials.
J Clin Oncol. 2024 Feb 23:JCO2301084. doi: 10.1200/JCO.23.01084. PMID: 38394473. Guidelines. ˍ




Sloan AR, Silver DJ, Kint S, Gallo M, Lathia JD.
Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?
Neuro Oncol. 2024 Feb 23:noae011. doi: 10.1093/neuonc/noae011. PMID: 38394444. Review˰ ˍ




Jacobo JA.
Central nervous system tumors of uncertain differentiation.
World Neurosurg X. 2024 Feb 24;22:100349. doi: 10.1016/j.wnsx.2024.100349. PMID: 38455248. Review. ˍ




Mohamed AA, Alshaibi R, Faragalla S, Mohamed Y, Lucke-Wold B.
Updates on management of gliomas in the molecular age.
World J Clin Oncol. 2024 Feb 24;15(2):178-194. doi: 10.5306/wjco.v15.i2.178. PMID: 38455131. Review. ˍ




Rayati M, Mansouri V, Ahmadbeigi N.
Gene therapy in glioblastoma multiforme: Can it be a role changer?
Heliyon. 2024 Feb 24;10(5):e27087. doi: 10.1016/j.heliyon.2024.e27087. PMID: 38439834. Review. ˍ




Rodriguez B, Rivera D, Zhang JY, Brown C, Young T, Williams T, Huq S, Mattioli M, Bouras A, Hadjpanayis CG.
Magnetic Hyperthermia Therapy for High-Grade Glioma: A State-of-the-Art Review.
Pharmaceuticals (Basel). 2024 Feb 26;17(3):300. doi: 10.3390/ph17030300. PMID: 38543086. Review. ˍ




Zhang H, Zhang H, Lin F, Huang B.
Latest Developments in Magnetic Resonance Imaging for Evaluating the Molecular Microenvironment of Gliomas.
Curr Med Imaging. 2024 Feb 26. doi: 10.2174/0115734056288909240219061430. PMID: 38415475. Review. ˍ




Jhanwar-Uniyal M, Zeller SL, Spirollari E, Das M, Hanft SJ, Gandhi CD.
Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
Cells. 2024 Feb 27;13(5):409. doi: 10.3390/cells13050409. PMID: 38474373. Review. ˍ




Nandoliya KR, Thirunavu V, Ellis E, Dixit K, Tate MC, Drumm MR, Templer JW.
Pre-operative predictors of post-operative seizure control in low-grade glioma: a systematic review and meta-analysis.
Neurosurg Rev. 2024 Feb 27;47(1):94. doi: 10.1007/s10143-024-02329-9. PMID: 38411788. Review; Meta-analysis˰ ˍ




Stepanenko AA, Sosnovtseva AO, Valikhov MP, Chernysheva AA, Abramova OV, Pavlov KA, Chekhonin VP.
Systemic and local immunosuppression in glioblastoma and its prognostic significance.
Front Immunol. 2024 Feb 28;15:1326753. doi: 10.3389/fimmu.2024.1326753. PMID: 38481999. Review. ˍ




*Tarev I, Cekov A.
Cerebellar Glioblastoma: A Literature Review and Case Analysis.
Cureus. 2024 Feb 28;16(2):e55135. doi: 10.7759/cureus.55135. PMID: 38558670. Case report; Review. ˍ




Apra C, Bemora JS, Palfi S.
Achieving gross total resection in neurosurgery: a review of intraoperative techniques and their influence on surgical goals.
World Neurosurg. 2024 Feb 29:S1878-8750(24)00341-3. doi: 10.1016/j.wneu.2024.02.128. PMID: 38431211. Review˰ ˍ




Ballestín A, Armocida D, Ribecco V, Seano G.
Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features.
Front Immunol. 2024 Feb 29;15:1347877. doi: 10.3389/fimmu.2024.1347877. PMID: 38487525. Review. ˍ




Fournel J, Hermier M, Martin A, Gamondès D, Tommasino E, Broussolle T, Morgado A, Baassiri W, Cotton F, Berthezène Y, Bani-Sadr A.
It Looks Like a Spinal Cord Tumor but It Is Not.
Cancers (Basel). 2024 Feb 29;16(5):1004. doi: 10.3390/cancers16051004. PMID: 38473365. Review. ˍ




Hasani F, Masrour M, Jazi K, Ahmadi P, Hosseini SS, Lu VM, Alborzi A.
MicroRNA as a potential diagnostic and prognostic biomarker in brain gliomas: a systematic review and meta-analysis.
Front Neurol. 2024 Feb 29;15:1357321. doi: 10.3389/fneur.2024.1357321. PMID: 38487328. Review; Meta-analysis. ˍ




Knopik-Skrocka A, Sempowicz A, Piwocka O.
Plasticity and resistance of cancer stem cells as a challenge for innovative anticancer therapies - do we know enough to overcome this?
EXCLI J. 2024 Feb 29;23:335-355. doi: 10.17179/excli2024-6972. PMID: 38655094. Review. ˍ




Otsuji R, Fujioka Y, Hata N, Kuga D, Hatae R, Sangatsuda Y, Nakamizo A, Mizoguchi M, Yoshimoto K.
Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid.
Cancers (Basel). 2024 Feb 29;16(5):1009. doi: 10.3390/cancers16051009. PMID: 38473369. Review. ˍ